Evidence map›Paper›PMID 41168136›Full record

ArticleJournal of cutaneous pathology2026

Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype.

Nidia Planella-Fontanillas, Andrea Molina-Alvarez, Lluís Colomo-Saperas, Roger Rovira, Monica Gonzàlez-Farré, Carlos Barranco-Sanz, Xavier Calvo, Clara Nadal-Pellisé, Fernando Gallardo, Ramon M Pujol

Abstract readCase Reports
In one paragraph

Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nidia Planella-FontanillasDepartment of Dermatology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.ORCID https://orcid.org/0009-0007-1303-2422
Andrea Molina-AlvarezDepartment of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID https://orcid.org/0009-0005-2037-408X
Lluís Colomo-SaperasDepartment of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain.ORCID https://orcid.org/0000-0001-5236-5085
Roger RoviraDepartment of Dermatology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Monica Gonzàlez-FarréDepartment of Pathology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Carlos Barranco-SanzDepartment of Pathology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Xavier CalvoLaboratori de Citologia Hematològica, Servei de Patologia, Grup de Recerca Translacional en Neoplàsies Hematològiques (GRETNHE), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.ORCID https://orcid.org/0000-0001-7934-9130
Clara Nadal-PelliséDepartment of Hematology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Fernando GallardoDepartment of Dermatology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Ramon M PujolDepartment of Dermatology, Hospital del Mar Research Institute (IMIM), Barcelona, Spain.ORCID https://orcid.org/0000-0002-5622-6055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An otherwise healthy 82-year-old woman presented with recurrent, asymptomatic erythematous papulo-nodular lesions on the face and extremities. A skin biopsy revealed a dense, non-epidermotropic lymphohistiocytic infiltrate with granulomatous features and a mixed population of medium-sized atypical lymphoid cells and plasma cells. Immunohistochemistry demonstrated a predominant CD4+ T-cell population with a T-follicular helper (TFH) phenotype (PD1+, CXCL13+, BCL6+), admixed with EBV-negative monotypic B-cells. Clonality was confirmed for both T and B cells by BIOMED2 PCR, and a RHOA p.G17V mutation was identified. Next-generation sequencing revealed additional mutations in TET2 and DNMT3A. Complete staging studies showed no nodal or visceral involvement. A minimal circulating population (0.11%) of atypical CD4+ T-cells with surface CD3 loss and TFH markers was detected in peripheral blood. Based on clinical and histopathological findings, a diagnosis of primary cutaneous peripheral T-cell lymphoma with TFH phenotype (pcPTCL-TFH) was made. The patient also developed a cutaneous squamous cell carcinoma, in which a peritumoral TFH lymphoid infiltrate with the same clonal features was identified. This case illustrates the diagnostic complexity of pcPTCL-TFH and its potential overlap with systemic TFH-derived lymphomas, underscoring the need for molecular work-up and close clinical follow-up to detect possible extracutaneous progression.

Indexed as

Lymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralSkin NeoplasmsT Follicular Helper CellsT-Lymphocytes, Helper-InducerAged, 80 and overCarcinoma, Squamous CellFemaleHumansPhenotype

Identifiers

PMID41168136
PMCPMC12779200

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.